About Celtic Biotech

At Celtic Biotech, we are developing innovative therapies for solid cancers and associated pain in human beings. Our products aim to be life-changing treatments for cancer patients, increasing survival rates, quality-of-life, and affordability for patients worldwide.   

We are using natural peptides isolated from snake venom to help the body fight cancer. Innovative, safe and effective treatments developed from venom neurotoxins have the potential to revolutionise the field of medicine and improve the lives of millions of patients worldwide. 

Our research focuses on solid tumours having the poorest outcomes, including non-small-cell lung cancer (NSCLC), which is the most common cause of cancer deaths globally. Our lead product, CB-24 (Crotoxin), is a potent neurotoxin that selectively targets and triggers programmed cell-death in cancerous cells, while sparing healthy cells.